Molecular Biomarkers & Diagnosis

Artificial Intelligence in the Identification and Validation of Molecular Biomarkers for Disease Detection

Abstract

Yuanyuan Zhang*

Artificial Intelligence (AI) has emerged as a powerful tool in modern healthcare, transforming the way diseases are diagnosed and treated. In particular, AI has proven invaluable in the identification and validation of molecular biomarkers, which are key indicators of disease presence, progression, and response to treatment. Molecular biomarkers, which include genetic, epigenetic, proteomic, and metabolomic markers, play a critical role in early disease detection, prognosis, and therapeutic decision-making.